Navigation Links
Imagenetix Reports Results of Offer to Extend Warrants
Date:12/21/2007

HREF="http://www.imagenetix.net" target="_new">http://www.imagenetix.net.

This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements are subject to risks and uncertainties that could cause actual results to vary materially from those projected in the forward-looking statements. The company may experience significant fluctuations in future operating results due to a number of economic, competitive, and other factors, including, among other things, the size and timing of customer contracts, new or increased competition, changes in market demand, and seasonality of purchases of the company's products and services. These factors and others could cause operating results to vary significantly from those in prior periods and those projected in forward-looking statements. Additional information with respect to these and other factors, which could materially affect the company and its operations, are included in certain forms the company has filed and will periodically file with the Securities Exchange Commission.


'/>"/>
SOURCE Imagenetix, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
2. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... ROCKVILLE, Md., Nov. 20 ...at it has priced an underwritten public offering o...to the public of $3.30 per share. The approximate...e underwriting discounts and commissions, will be ...f our VLP-based vaccines, internal research and de...
(Date:11/20/2009)... METTLER TOLEDO recently announced th...ss Optimization Using At-Line Particle Characteriz...9. In this webinar, the application of in situ pa... design space and optimize a series of roller comp...s, and roller compaction forces. , ...
(Date:11/19/2009)...PENHAGEN, Nov. 19 Danish Prince Jo...ulosic ethanol plant in Kalundborg, Denmark, on We...orld,s first and largest 2nd generation ethanol de...enzymes are used in the plant,s innovative process...n of Danisco, was the first to market with commerc...
(Date:11/19/2009)... ,, BETHESDA, Md., Nov. 19 /PRNewswire-Firs...n innovator in biotechnology for diabetes therapy,...ting services to food, supplement, biotechnology a...osed the previously reported $6.3 million register...2,760,870 shares of its common stock and warrants ...
Breaking Biology Technology:Novavax Prices Public Offering of Common Stock 2Roller Compaction Process Optimization Using At-Line Particle Characterization 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3
... Service Industries debuts PAKS...ne for medical pouches & sachets from Ireland-... Belfast, Ireland (PRWEB) March 16, 2009 -- A l... pouches and sachets which is manufactured by Nort...debut through U.S. distributor Service Industries ...
...IEGO, March 16 Prometheus Laboratories Inc., a sp...ounced today that it has received New York State a...t and only blood test for irritable bowel syndrome...s, two of which are proprietary, along with a prop...ents with IBS. , , "One out of five Americans has...
...LE, March 16 /PRNewswire-FirstCall/ - Oncothyreon ... company specializing in the development of innova...cer, today announced that on March 12, 2009, it re...t Oncothyreon had re-gained full compliance with t...l Market. , The notice followed a review of Oncoth...
Other Biology Technology:U.S. Distributor Debut for PAKSCAN - a Pouch & Sachet Leak Tester Machine from Ireland-based Sepha Ltd. 2U.S. Distributor Debut for PAKSCAN - a Pouch & Sachet Leak Tester Machine from Ireland-based Sepha Ltd. 3Prometheus Receives New York State Approval for PROMETHEUS(R) IBS Diagnostic, First Blood Test for Irritable Bowel Syndrome 2Oncothyreon regains compliance with NASDAQ listing requirements 2
(Date:11/19/2009)...ov. 19 BIO-key Internati... wireless public safety and finger-based biometric...ial Shareholder Meeting held today was adjourned w... not present. ,, (Logo: http://www.newscom.com...impressive 99.3% of the 35 million votes cast vote...
(Date:11/19/2009)...due University scientists have helped identify and...l wall development in maize, an effort that expand...omass best suited for biofuels production. , The...fessor of plant cell biology, published their find...ant Physiology on Thursday (Nov. 19). They also w...
(Date:11/19/2009)...s Competitive NIH Director,s T-R01 Award , Speedi..., Dr. Samie Jaffrey, associate professor of phar...g the first researchers to win a prestigious NIH D...al Institutes of Health. Dr. Jaffrey and his colle...n technologies that may some day speed up lab test...
Breaking Biology News(10 mins):BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3Maize cell wall genes identified, giving boost to biofuel research 2Weill Cornell science briefs: November 2009 2Weill Cornell science briefs: November 2009 3Weill Cornell science briefs: November 2009 4Weill Cornell science briefs: November 2009 5Glaucoma Tied to Gene Variants in Blacks 57942 1Glaucoma Tied to Gene Variants in Blacks 57942 2Juice Newton Performs Benefit Concert to Support Dystonia Research 57937 1Juice Newton Performs Benefit Concert to Support Dystonia Research 57937 2Cohera Medical Receives ISO 13485 Certification 3A Company Meets International Standards for Design Development and Manufacturing of Medical Devices 57932 1Cohera Medical Receives ISO 13485 Certification 3A Company Meets International Standards for Design Development and Manufacturing of Medical Devices 57932 2
...ven false established medical practice that an ant...liver infections was safe to use on its own in pat...trate that treatment with entecavir leads to cross... the AIDS virus. , "Our results show that entecavi...wn to be active against HIV - it breeds resistance...
...ealth care and medicine, but current technologies ...keup. Any patient wanting a complete picture of th... at the sight of the bill -- to the current tune o...ammalian-sized genome sequenced. , Now, with a gra...nstitute (NHGRI), scientists at the Biodesign Inst...
...sonous bites they use for defense. But what can no...t if they could borrow a dose of poison by eating ...s exactly what happens in the relationship between...o a team of researchers funded by the National Sci...nismal Systems (IOS). , Herpetologists Deborah ...
Other Biology News:Widely used hepatitis B drug spurs HIV drug resistance 2Widely used hepatitis B drug spurs HIV drug resistance 3Faster, low cost sequencing technologies needed to drive era of personalized medicine 2Faster, low cost sequencing technologies needed to drive era of personalized medicine 3Nonvenomous Asian snakes 'borrow' defensive poison from toxic toads 2
Solvent-Detergent Removal Resin from Sigma-Aldrich
...station automates a wide array of research and dia...ample Preparation to Bio-Molecular and Cell Based ...er Sciclone enables numerous combinations of pipet... needs of a given application, and should the unit...
Nunc OmniTray from Sigma-Aldrich
...m Caliper represents a revolutionary breakthrough ...rst time the ability to generate real-time perform...onditions. In addition, each channel automaticall...ges in temperature, and offers its own liquid leve...
Biology Products: